Endo Tools Therapeutics (ETT) this week announced the first U.S. commercial cases using its Endomina system.
Gosselies, Belgium-based ETT designed Endomina for endoscopic placement of sutures and approximation of soft tissue in the gastrointestinal tract. The first procedures were performed at Brigham and Women’s Hospital in Boston, Massachusetts by Drs. Chris Thompson and Pichamol Jirapinyo.
“We are thrilled to be the first hospital in the U.S. to perform gastric procedures using the Endomina system. The system offers a minimally invasive option with a large working space to approximate very large plications,” Thompson said in a news release. “I look forward to incorporating Endomina into my daily practice, as I found it particularly easy to learn and use due to its unique design.”
The Endomina system has a triangulation platform and suturing units. It can be affixed to standard endoscopes for a bendable therapeutic channel that moves independently. It allows physicians to perform suturing like a laparoscopic intervention through the mouth. ETT’s Endomina is CE marked in Europe and has received FDA 510(k) clearance.
“We are delighted the Endomina system is now available to patients and physicians in the U.S. market,” CEO Alexandre Chau said. “The successful completion of these first cases in the U.S. demonstrates potential for this technology to improve the lives of patients undergoing gastric surgery.”
